(Q33718622)

28 July 2017

title

Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer (English)

1 reference

28 July 2017

1 reference

1 reference

1 reference

Marco A de Velasco

5

0 references

Masatoshi Kudo

object named as

Masatoshi Kudo

12

0 references

author name string

Yosuke Togashi

1

1 reference

28 July 2017

Hiroki Sakamoto

2

1 reference

28 July 2017

Hidetoshi Hayashi

3

1 reference

28 July 2017

Masato Terashima

4

1 reference

28 July 2017

Yoshihiko Fujita

6

1 reference

28 July 2017

Yasuo Kodera

7

1 reference

28 July 2017

Kazuko Sakai

8

1 reference

28 July 2017

Shuta Tomida

9

1 reference

28 July 2017

Masayuki Kitano

10

1 reference

28 July 2017

Akihiko Ito

11

1 reference

28 July 2017

Kazuto Nishio

13

1 reference

28 July 2017

publication date

27 May 2014

1 reference

28 July 2017

1 reference

28 July 2017

volume

13

1 reference

28 July 2017

page(s)

126

1 reference

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Targeting the TGFβ signalling pathway in disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Molecular pathways in pancreatic carcinogenesis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Effects of activin and TGFβ on p21 in colon cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

The emerging role of the TGFβ tumor suppressor pathway in pancreatic cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

FGFR2 gene amplification and clinicopathological features in gastric cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Integrated analysis of whole genome exon array and array-comparative genomic hybridization in gastric and colorectal cancer cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Non-Smad signaling pathways

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Transforming growth factor beta in pancreatic cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Activin is a potent growth suppressor of epithelial ovarian cancer cells.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Establishment and molecular profiling of a novel human pancreatic cancer panel for 5-FU.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

p21Waf1/Cip1 as a therapeutic target in breast and other cancers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Pancreatic cancer biology and genetics

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cel

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

28 July 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-13-126

Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-13-126

TGFbeta signalling: a complex web in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-13-126

Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-13-126

Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-13-126

Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-13-126

Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-13-126

Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2/M transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-13-126

Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047430

Expression of activin A and follistatin core proteins by human prostate tumor cell lines

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24886203

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24886203

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1476-4598-13-126

1 reference

Dimensions Publication ID

28 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1476-4598-13-126

9 September 2019

1 reference

28 July 2017

1 reference